Endosynbiology Endosynbiology The use of engineered bacterial - - PowerPoint PPT Presentation

endosynbiology endosynbiology the use of engineered
SMART_READER_LITE
LIVE PREVIEW

Endosynbiology Endosynbiology The use of engineered bacterial - - PowerPoint PPT Presentation

Endosynbiology Endosynbiology The use of engineered bacterial endosymbionts to create synthetic organelles in host cells. ENDOSYMBIOSIS mitochondria ancient heterotrophic proteobacteria protection nutrients ENDOSYMBIOSIS Pea aphid


slide-1
SLIDE 1
slide-2
SLIDE 2

Endosynbiology Endosynbiology The use of engineered bacterial endosymbionts to create synthetic

  • rganelles in host cells.
slide-3
SLIDE 3

ENDOSYMBIOSIS

ancient heterotrophic proteobacteria mitochondria protection nutrients

slide-4
SLIDE 4

ENDOSYMBIOSIS

Pea aphid Nutrient-poor diet of sap Bacteriome housing endosymbionts

slide-5
SLIDE 5
slide-6
SLIDE 6

APPLICATIONS

autoimmune

Many disorders can be attributed to a dysfunctional or absent gene or gene product

cancers

siRNA silencing of oncogenes for cancer therapy Monoclonal antibody therapy targeting autoreactive antibodies

slide-7
SLIDE 7

OUTLINE

making endosymbionts the pHlow system

regulation containment

biosafety symbiont candidates and future work

slide-8
SLIDE 8

MAKING ENDOSYMBIONTS

how to turn a free-living bacterium into an endosymbiont:

Facilitate entry into cell Ensure stable survival and replication Design secretion of useful product

slide-9
SLIDE 9

A PRE-EXISTING SYSTEM

Warsaw 2009 & 2010 designed a protein delivery system utilising Invasin and Listeriolysin O.

Surface protein derived from Yersinia enterocolitica. A secreted hemolysin derived from Listeria monocytogenes.

Invasin (INV) Listeriolysin O (LLO

slide-10
SLIDE 10

HOW THE SYSTEM WORKS

  • 1. Invasin binds to β1-

integrins

  • 2. Endosymbiont is

endocytosed

  • 3. Listeriolysin breaks

down the endosome

  • 4. Entry is complete

(1) (2) (3) (4)

slide-11
SLIDE 11

pHLOW- MEDIATED ENTRY

slide-12
SLIDE 12

pH INDUCIBLE PROMOTERS

1.

  • 1. E. coli
  • E. coli acid shock

acid shock response esponse (BBa_K1170000) 2.

  • 2. L.
  • L. lactis

lactis p170 p170 (BBa_K1677300) 3.

  • 3. L.
  • L. lactis

lactis p170-CP25 p170-CP25 hybrid hybrid (BBa_K1677301)

as the pH in the endosome drops, it induces expression of listeriolysin O

slide-13
SLIDE 13

CRE-LOX RECOMBINATION

slide-14
SLIDE 14

RNA PSEUDOKNOTS

RNA secondary structures between ORFs cause translational delay BBa_K1677391: IBV pseudoknot

Design:

  • Start codons were removed from viral sequences
  • 20bp were added upstream and downstream of the

pseudoknots

  • Placed outside of ORFs

BBa_K1677369: MMTV pseudoknot BBa_K1677743: TGV pseudoknot BBa_K1677666: HCV229E pseudoknot

slide-15
SLIDE 15

STRUCTURAL MODELLING

Structures were predicted using DotKnot and visualised using PseudoViewer.

MMTV 1x Global MMTV 3x Global

Sperschneider, J., Datta, A., DotKnot: pseudoknot prediction using the probability dot plot under a refined energy model. Nucleic acids research 2010, 38, e103. Sperschneider, J., Datta, A., Wise, M. J., Heuristic RNA pseudoknot prediction including intramolecular kissing hairpins. Rna 2011, 17, 27-38.

slide-16
SLIDE 16

STRUCTURAL MODELLING

TGV 3x Global TGV 1x Global

Structures were predicted using DotKnot and visualised using PseudoViewer.

slide-17
SLIDE 17

TOXIN-ANTITOXIN SYSTEM

Isolated from P . aeruginosa Antitoxin binds toxin preventing cell death Prevents: Escape of recombinant bacteria Horizontal Gene transfer

With no IPTG With IPTG

slide-18
SLIDE 18

CONTAINMENT

  • 1. arabinose-dependent expression of invasin
  • 2. constitutive expression of toxin
  • 3. IPTG-dependent expression of antitoxin
  • 4. Cre-lox deletion of invasive genes
slide-19
SLIDE 19

BIOSAFETY

slide-20
SLIDE 20

ENDOSYMBIONTS

slide-21
SLIDE 21
  • Lactic acid bacteria model organism
  • Gram positive + anaerobic
  • Low immunogenicity + anti-oxidative ability
  • Part of healthy human microbiome
  • Generally Regarded As Safe (GRAS)

BBa_K1677103: LysM-INV BBa_K1677101: LLO (codon (codon optimised

  • ptimised)

)

ENDOSYMBIONT CANDIDATE 1: LACTOCOCCUS LACTIS

slide-22
SLIDE 22

ENDOSYMBIONT CANDIDATE 2: SYNECHOCYSTIS PCC6803

  • Freshwater cyanobacteria

model organism

  • 1-2 day generation time
  • Previous evidence of survival

Integrative plasmids psbA2 and pCPC

Agapakis, C. M., Niederholtmeyer, H., Noche, R. R., Lieberman, T. D., Megason, S. G., Way, J. C., & Silver, P. A. (2011). Towards a synthetic chloroplast. PLoS One, 6(4), e18877.

slide-23
SLIDE 23

Synechocystis PCC6803 Lactococcus lactis Escherichia coli K12

Sources: http://veja0.abrilm.com.br/assets/images/2011/5/38595/Escherichia-coli-surto-alemanha-20110530-size-598.bmp , http://w3.unisa.edu.au/ciam/groups/bg/images/synechocystis.jpg,, http://textbookofbacteriology.net/Lactococcusnewtdb.jpg , http://www.atcc.org/~/media/Attachments/F/1/2/8/1768.ashx,

HelaT CHO-7 BHK21

slide-24
SLIDE 24

FUTURE WORK

population control transmission during cell division cell specific targeting post- translational modifications

quorum sensing mitochondrial model

  • ther invasin/

adhesin proteins coexpression

  • f enzymes
slide-25
SLIDE 25

HUMAN PRACTICES

  • Biosafety
  • Endosymbiont choice
  • Communication strategy
  • Pseudoknots and intellectual property
  • Hosted Aussie iGEM meet up
  • Outreach projects
  • Make your own GMO high school workshop

(collaboration with UNSW Aspire and UNSW Biomod team)

  • BABS UNSW ethics debate
slide-26
SLIDE 26
  • Used previously existing biobricks (INV and LLO) to design a

more efficient and safe cellular entry system (pHlow)

  • Improved characterisation of two previously existing biobricks

(CP44 and ASR promoter)

  • Submitted and characterised new pH inducible promoter (L.

lactis P170)

  • Submitted three individual pseudoknot biobricks and

conducted structural modeling

  • Submitted three pseudoknots downstream from IPTG-

inducible promoters

  • Invented new containment mechanism (toxin + anti-toxin)
  • Submitted a complete cellular entry system for Lactococcus

(LysM-INV + LLO)

  • Adapted integrative plasmids to be biobrick compatible
  • Optimised Lactococcus and Synechocystis transformation

protocols

ACHIEVEMENTS

slide-27
SLIDE 27

QUESTIONS?

slide-28
SLIDE 28

Anaer Anaerobic

  • bic

Aer Aerobic

  • bic

Heter Heterotr

  • trophic
  • phic

Autotr Autotrophic

  • phic
  • E. coli

x x

  • L. lactis

x x Synechocystis x x x

slide-29
SLIDE 29

ENDOSYMBIONT 1:

  • E. COLI
  • Ubiquitous synthetic biology

chassis

  • Comparability to previous

research (Agapakis, 2011)

  • Poor public perception
  • 20 minute generation time

Agapakis, C. M., Niederholtmeyer, H., Noche, R. R., Lieberman, T. D., Megason, S. G., Way, J. C., & Silver, P. A. (2011). Towards a synthetic chloroplast. PLoS One, 6(4), e18877.

slide-30
SLIDE 30

ENTEROINVASIVE E. COLI STRAINS

slide-31
SLIDE 31

Synechocystis PCC6803 Lactococcus lactis Escherichia coli K12

Sources: http://veja0.abrilm.com.br/assets/images/2011/5/38595/Escherichia-coli-surto-alemanha-20110530-size-598.bmp , http://w3.unisa.edu.au/ciam/groups/bg/images/synechocystis.jpg,, http://textbookofbacteriology.net/Lactococcusnewtdb.jpg , http://www.atcc.org/~/media/Attachments/F/1/2/8/1768.ashx,

HelaT CHO-7 BHK21

pH, temperature, ratio of cell densities, incubation times, glucose concentration